Oral Formulation of Clonidine and Midazolam for Sedation in Dental Procedures
AssigneeTransdermal Sedation Solutions, LLC
InventorsPamala Lea Wilson, James Liddell McCarley
Life of this patent
Estimating the term…
Abstract
A drug composition in solid drug matrix formulation comprising clonidine, midazolam, and fentanyl. The amounts of the drug contained in the solid drug matrix are sufficient to induce sedation in preparation for a clinical procedure. When administered in the mouth, the drug ingredients are absorbed by transmucosal passage. This solid drug matrix formulation may be particularly useful in pediatric dentistry practice. Also disclosed is a method of inducing sedation in a patient by administering the solid drug matrix formulation to the patient prior to performing a clinical procedure.
Claims20
A solid drug matrix formulation comprising:
- clonidine in an amount ranging from 10-300 μg;
- midazolam in an amount ranging from 1-40 mg;
- fentanyl in an amount ranging from 10-300 μg.
Dependencies are inferred from the claim text.